I love a good industrial story, particularly when companies can spike
improving volumes and mix with better manufacturing margins. Along those
same lines, I'm broadly a fan of companies whose products show up
almost everywhere but don't necessarily capture much investor
"mind-share". All of that said, I can't bring myself to love H.B. Fuller
(FUL). I do
understand that this specialty chemicals company can benefit from
significant margin improvement initiatives and recoveries in key end
markets like construction, but the valuation seems to be more than
generous for that potential.
To read more, please click below:
Investors Seem To Be Expecting Too Much From H.B. Fuller
No comments:
Post a Comment